MAOA has been demonstrated to promote prostate tumorigenesis and cancer metastasis, and this study revealed that WCE inhibited MAOA expression, a promising therapeutic effect (Wu et al., 2014). The gene discussed is MAOA; the disease is urogenital neoplasm.